Experience on postmortem minimally invasive tissue sampling to ascertain the cause of death determination in South African children: A case for implementing as standard of care

Authors

  • J du Toit South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • K Storath South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • I Dunn South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • P Makekeng South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • M Moosa South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • K Mothibi South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • N Umuneza South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • C A Rees Division of Pediatric Emergency Medicine, Emory University School of Medicine, Atlanta, USA; Department of Emergency Medicine, Children’s Healthcare of Atlanta, USA
  • D Blau Global Health Center, US Centers for Disease Control and Prevention, Atlanta, USA
  • S Lala Office for Teaching and Learning; and Paediatric Education and Research Ladder, Department of Paediatrics and Child Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • Y Adam Department of Obstetrics and Gynaecology, University of the Witwatersrand, and Chris Hani Baragwanath Academic HospitalJohannesburg, South Africa
  • S Velaphi Department of Paediatrics and Child Health, School of Clinical Medicine, Faculty of Health Sciences, Chris Hani Baragwanath Academic Hospital and University of the Witwatersrand, Johannesburg, South Africa
  • M Hale Department of Anatomical Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • P Swart Department of Anatomical Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • J Wadula epartment of Clinical Microbiology and Infectious Diseases, Faculty of Health Sciences, University of Witwatersrand, National Health Laboratory Services, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa
  • L Mothibi Department of Clinical Microbiology and Infectious Diseases, Faculty of Health Sciences, University of Witwatersrand, National Health Laboratory Services, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa
  • A Wise Rahima Moosa Mother and Child Hospital, Obstetrics and Gynaecology, University of the Witwatersrand, Johannesburg, South Africa
  • V Baba Department of Obstetrics and Gynaecology, University of the Witwatersrand, and Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa
  • P Jaglal Department of Clinical Microbiology and Infectious Diseases, Faculty of Health Sciences, University of Witwatersrand, National Health Laboratory Services, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa
  • S Mahtab South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • S Madhi South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Wits Infectious Diseases and Oncology Research Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
  • Z Dangor South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

DOI:

https://doi.org/10.7196/SAMJ.2024.v114i2.1538

Keywords:

Paediatric, Infectious diseases, Postmoterm

Abstract

Determining the death burden for prioritising public health interventions necessitates detailed data on the causal pathways to death. Postmortem minimally invasive tissue sampling (MITS), incorporating histology, molecular and microbial culture diagnostics, enhances cause-of-death attribution, particularly for infectious deaths. MITS proves a valid alternative to full diagnostic autopsies, especially in low- and middle-income countries. In Soweto, South Africa (SA), the Child Health and Mortality Prevention Surveillance (CHAMPS) programme has delineated over 1 000 child and stillbirth deaths since 2017. This SA CHAMPS site supports advocating for the use of postmortem MITS as routine practice, for more granular insights into under-5 mortality causes. This knowledge is crucial for SA’s pursuit of Sustainable Development Goal 3.2, targeting reduced neonatal and under-5 mortality rates. This commentary explores the public health advantages and ethicolegal considerations surrounding implementing MITS as standard of care for stillbirths, neonatal and paediatric deaths in SA. Furthermore, based on the data from CHAMPS, we present three pragmatic algorithmic approaches to the wide array of testing options for cost-effectiveness and scalability of postmortem MITS in South African state facilities.

Author Biographies

  • K Storath, South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Clincial associate, Wits VIDA

  • I Dunn, South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Masters of Public Health candidate

  • P Makekeng, South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Clinical associate - Wits Vida

  • M Moosa, South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Clinical associate - Wits Vida

  • K Mothibi, South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Clinical associate - Wits Vida

  • N Umuneza, South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Clinical associate - Wits Vida

  • C A Rees, Division of Pediatric Emergency Medicine, Emory University School of Medicine, Atlanta, USA; Department of Emergency Medicine, Children’s Healthcare of Atlanta, USA

    Assistant Professor of Pediatrics and Emergency Medicine, Emory University School of Medicine 

    Research Director, Pediatric Emergency Medicine Fellowship, Emory University School of Medicine 

    Attending Physician, Children's Healthcare of Atlanta

    Pediatric Research Scientist, CHAMPS, U.S. Program Office 

  • D Blau, Global Health Center, US Centers for Disease Control and Prevention, Atlanta, USA

    Senior Director for Science at Centres for Disease Control and Prevention (CDC)

    Laboratory and Diagnostics Lead for CHAMPS

  • S Lala, Office for Teaching and Learning; and Paediatric Education and Research Ladder, Department of Paediatrics and Child Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    MBBCh, PhD

  • Y Adam, Department of Obstetrics and Gynaecology, University of the Witwatersrand, and Chris Hani Baragwanath Academic HospitalJohannesburg, South Africa

    MBBCh, FCOG(SA)

  • S Velaphi, Department of Paediatrics and Child Health, School of Clinical Medicine, Faculty of Health Sciences, Chris Hani Baragwanath Academic Hospital and University of the Witwatersrand, Johannesburg, South Africa

    Paediatric Head of Department, Chris Hani Baragwanath Hospital

    MBChB, PhD

  • S Mahtab, South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    Senior Program Manager for CHAMPS at Wits Vida

    MBBS, MPH, PhD

  • S Madhi, South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Wits Infectious Diseases and Oncology Research Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    MBBCh, PhD

    Dean: Faculty of Health Sciences | University of the Witwatersrand, Johannesburg

    Professor of Vaccinology

    Director: Vaccines & Infectious Diseases Analytics Research Unit (Wits-VIDA)

    Co-Director: African Leadership in Vaccinology Expertise (ALIVE)

  • Z Dangor, South African Medical Research Council Vaccines and Infectious Diseases Analytics Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

    MBBCh, PhD

    Research Director: Wits VIDA

    Paediatric Pulmonologist: Department of Paediatrics and Child Health

    University of the Witwatersrand

References

CHAMPS.TheCHAMPSstory.https://champshealth.org/about/.(accessed2February2023).

Salzberg NT, Sivalogan K, Bassat, Q. Mortality surveillance methods to identify and characterise deaths in child health and mortality prevention surveillance network sites. Clin Infect Dis 2019;69(Suppl 4):S262-S273. https://

doi.org/10.1093/cid/ciz599

Rakislova N, Jordao D, Ismail MR. Accuracy of verbal autopsy, clinical data and minimally invasive autopsy in the evaluation of malaria-specific mortality: An observational study. BMJ Glob Health 2021;6(6):e005218. https://doi. org/10.1136/bmjgh-2021-005218

MathersCD,BoermaT,MaFatD.Globalandregionalcausesofdeath.BrMedBull2009;92(1):7-32.https://doi. org/10.1093/bmb/ldp028

Fligner CL, Murray J, Roberts DJ. Synergism of verbal autopsy and diagnostic pathology autopsy for improved accuracy of mortality data. Popul Health Metr 2011;9(1):25. https://doi.org/10.1186/1478-7954-9-25

DasM,AroraN,RasailyR.Perceptionsofthehealthcareprovidersregardingacceptabilityandconductofminimal invasive tissue sampling (MITS) to identify the cause of death in under-five deaths and stillbirths in North India: A qualitative study. BMC Health Serv Res 2020;20(1):833. 10.1186/s12913-020-05693-6

Lawn JE, Blencowe H, Waiswa P. Stillbirths: Rates, risk factors, and acceleration towards 2030. Lancet 2016;387(10018):587-603. https://doi.org/10.1016/S0140-6736(15)00837-5

MunguambeK,MaixenchsM,AnselmoR.Consenttominimallyinvasivetissuesamplingproceduresinchildren in Mozambique: A mixed-methods study. PLoS ONE 2021;16(11):e0259621. https://doi.org/10.1371/journal. pone.0259621

Maixenchs M, Anselmo R, Zielinksi-Gutierrez E. Willingness to know the cause of death and hypothetical acceptability of the minimally invasive autopsy in six diverse African and Asian settings: A mixed methods socio- behavioural study. PLoS Med 2016;13(11):e1002172. https://doi.org/10.1371/journal.pmed.1002172

Paganelli CR, Goco NJ, McClure EM. The evolution of minimally invasive tissue sampling in postmortem examination: A narrative review. Glob Health Action 2020;13(1):1792682. https://doi.org/10.1080/16549716.202 0.1792682

MenendezC,CastilloP,MartinezMJ.Validityofaminimallyinvasiveautopsyforcauseofdeathdeterminationin stillborn babies and neonates in Mozambique: An observational study. PLoS Med 2017;14(6):e1002318. https://doi. org/10.1371/journal.pmed.1002318

Rakislova N, Fernandes F, Lovane L. Standardisation of minimally invasive tissue sampling specimen collection and pathology training for the child health and mortality prevention surveillance network. Clin Infect Dis 2019;69(Suppl 4):S302-S310. https://doi.org/10.1093/cid/ciz565

Hailu R, Desta T, Berkuretsion Y. Minimally invasive tissue sampling in preterm deaths: A validation study. Glob Pediatric Health 2020;7:2333794X20953263. 10.1177/2333794X20953263

TankoNM,BakytkalyI,IssanovA.Validatingaminimallyinvasivetissuesampling(MITS)methodindetermining cause of death in stillbirths and neonates. Children 2021;8(12):1095. https://doi.org/10.3390/children8121095

TaylorAW,BlauDM,BassatQ.Initialfindingsfromanovelpopulation-basedchildmortalitysurveillanceapproach:

A descriptive study. Lancet Glob Health 2020;8(7):e909-e919. https://doi.org/10.1016/S2214-109X(20)30205-9

Diaz MH, Waller JL, Theodore MJ. Development and implementation of multiplex TaqMan array cards for specimen testing at Child Health and Mortality Prevention Surveillance site laboratories. Clin Infect Dis

;69(Suppl 4):S311-S321. https://doi.org/10.1093/cid/ciz571

MartinesRB,RitterJM,GaryJ.PathologyandtelepathologymethodsintheChildHealthandMortalityPrevention

Surveillance network. Clin Infect Dis 2019;69(Suppl 4):S322-S332. https://doi.org/10.1093/cid/ciz579

Breiman RF, Blau DM, Mutevedzi P. Postmortem investigations and identification of multiple causes of child deaths: An analysis of findings from the Child Health and Mortality Prevention Surveillance (CHAMPS) network.

PLoS Med 2021;18(9):e1003814. https://doi.org/10.1371/journal.pmed.1003814

Mahtab S, Madhi SA, Baillie VL. Causes of death identified in neonates enrolled through Child Health and

Mortality Prevention Surveillance (CHAMPS), December 2016 - December 2021. PLOS Glob Public Health 2023;

(3): e0001612. https://doi.org/10.1371/journal.pgph.0001612

World Health Organization. Cause of death certification flyer: A tool for certifying physicians. Geneva: WHO,

SouthAfrica.ConstitutionoftheRepublicofSouthAfrica.1996.

BuneiM,MuturiP,OtiatoF.Factorsinfluencingacceptanceofpost-mortemexaminationofchildrenatatertiary

care hospital in Nairobi, Kenya. Ann Glob Health 2019;85(1):95. https://doi.org/10.5334/aogh.2504

Ben-Sasi K, Chitty LS, Franck LS. Acceptability of a minimally invasive perinatal/paediatric autopsy: Healthcare professionals’ views and implications for practice. Prenat Diagn 2013;33(4):307-312. https://doi.org/10.1002/

pd.4077

Statistics South Africa. Mortality and causes of death in South Africa: Findings from death notification 2018. Pretoria: Stats SA, 2018.

Toit-PrinslooLD.PerformanceofautopsiesinSouthAfrica:Selectedlegalandethicalperspectives.ContinuingMed Educ 2012;30(2):53-55. http://www.cmej.org.za/index.php/cmej/article/view/2326/2188 (accessed 26 June 2023). 26. Anyango L. Nutrition investment evidence. Kisumu, 2023. https://www.kisumu.go.ke/nutrition-investment-

evidence/ (accessed 23 May 2023).

Morrison LTR, Brown EG, Paganelli CR. Cost evaluation of minimally invasive tissue sampling (MITS)

implementation in low- and middle-income countries. Clin Infect Dis 2021;73(Suppl 5):S401-S407. https://doi.

org/10.1093/cid/ciab828

AminuM,Bar-ZeevS,WhiteS.Understandingcauseofstillbirth:Aprospectiveobservationalmulti-countrystudy from sub-Saharan Africa. BMC Pregn Childbirth 2019;19(1):470. https://doi.org/10.1186/s12884-019-2626-7

Madhi SA, Pathirana J, Baillie V. An observational pilot study evaluating the utility of minimally invasive tissue

sampling to determine the cause of stillbirths in South African women. Clin Infect Dis 2019;69(Suppl 4):S342-S350.

https://doi.org/10.1093/cid/ciz573

Madhi SA, Pathirana J, Baillie V. Unraveling specific causes of neonatal mortality using minimally invasive tissue sampling: an observational study. Clin Infect Dis 2019;69(Suppl 4):S351-S360. 10.1093/cid/ciz574

Chawana R, Baillie V, Izu A. Potential of minimally invasive tissue sampling for attributing specific causes of childhood deaths in South Africa: A pilot, epidemiological study. Clin Infect Dis 2019;69(Suppl 4):S361-S373. 10.1093/cid/ciz550

Downloads

Published

2024-02-13

Issue

Section

Research

How to Cite

1.
du Toit J, Storath K, Dunn I, Makekeng P, Moosa M, Mothibi K, et al. Experience on postmortem minimally invasive tissue sampling to ascertain the cause of death determination in South African children: A case for implementing as standard of care. S Afr Med J [Internet]. 2024 Feb. 13 [cited 2025 Mar. 23];114(2):e1538. Available from: https://samajournals.co.za/index.php/samj/article/view/1538

Most read articles by the same author(s)